Physician profile
Simon Burke
NPI 1023701174
$2,896.91
in general payments reported to CMS, 2019-2025
9 companies · $2,342 in 2025
The $2,342 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $176 · 2024: $380 · 2025: $2,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872 · Travel and Lodging: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.59 |
| Travel and Lodging | $1,025.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,781.88 | 2023-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Citrefix |
| Acumed LLC | $356.00 | 2025 | Acumed |
| Paragon 28, INC. | $190.33 | 2025 | Silverback |
| Organogenesis INC. | $131.63 | 2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Medline Industries Lp | $125.74 | 2025 | |
| Linvatec Corporation | $123.73 | 2024 | Biobrace 23mm |
| Treace Medical Concepts, INC. | $122.21 | 2024 | |
| Titan Surgical Group, LLC | $40.51 | 2023-2024 | |
| Ani Pharmaceuticals, INC. | $24.88 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.